IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-41821-6.html
   My bibliography  Save this article

An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering

Author

Listed:
  • Gaofeng Cui

    (Mayo Clinic)

  • Maria Victoria Botuyan

    (Mayo Clinic)

  • Pascal Drané

    (Dana-Farber Cancer Institute)

  • Qi Hu

    (Mayo Clinic)

  • Benoît Bragantini

    (Mayo Clinic)

  • James R. Thompson

    (University of Minnesota)

  • David J. Schuller

    (Cornell University)

  • Alexandre Detappe

    (Institut de Cancérologie Strasbourg Europe)

  • Michael T. Perfetti

    (University of North Carolina at Chapel Hill)

  • Lindsey I. James

    (University of North Carolina at Chapel Hill
    University of North Carolina at Chapel Hill School of Medicine)

  • Stephen V. Frye

    (University of North Carolina at Chapel Hill
    University of North Carolina at Chapel Hill School of Medicine)

  • Dipanjan Chowdhury

    (Dana-Farber Cancer Institute)

  • Georges Mer

    (Mayo Clinic
    Mayo Clinic)

Abstract

The recruitment of 53BP1 to chromatin, mediated by its recognition of histone H4 dimethylated at lysine 20 (H4K20me2), is important for DNA double-strand break repair. Using a series of small molecule antagonists, we demonstrate a conformational equilibrium between an open and a pre-existing lowly populated closed state of 53BP1 in which the H4K20me2 binding surface is buried at the interface between two interacting 53BP1 molecules. In cells, these antagonists inhibit the chromatin recruitment of wild type 53BP1, but do not affect 53BP1 variants unable to access the closed conformation despite preservation of the H4K20me2 binding site. Thus, this inhibition operates by shifting the conformational equilibrium toward the closed state. Our work therefore identifies an auto-associated form of 53BP1—autoinhibited for chromatin binding—that can be stabilized by small molecule ligands encapsulated between two 53BP1 protomers. Such ligands are valuable research tools to study the function of 53BP1 and have the potential to facilitate the development of new drugs for cancer therapy.

Suggested Citation

  • Gaofeng Cui & Maria Victoria Botuyan & Pascal Drané & Qi Hu & Benoît Bragantini & James R. Thompson & David J. Schuller & Alexandre Detappe & Michael T. Perfetti & Lindsey I. James & Stephen V. Frye &, 2023. "An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41821-6
    DOI: 10.1038/s41467-023-41821-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-41821-6
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-41821-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Tarun S. Nambiar & Pierre Billon & Giacomo Diedenhofen & Samuel B. Hayward & Angelo Taglialatela & Kunheng Cai & Jen-Wei Huang & Giuseppe Leuzzi & Raquel Cuella-Martin & Andrew Palacios & Anuj Gupta &, 2019. "Stimulation of CRISPR-mediated homology-directed repair by an engineered RAD18 variant," Nature Communications, Nature, vol. 10(1), pages 1-13, December.
    2. Jordan R. Becker & Gillian Clifford & Clara Bonnet & Anja Groth & Marcus D. Wilson & J. Ross Chapman, 2021. "BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination," Nature, Nature, vol. 596(7872), pages 433-437, August.
    3. Yaxin Dai & Aili Zhang & Shan Shan & Zihua Gong & Zheng Zhou, 2018. "Structural basis for recognition of 53BP1 tandem Tudor domain by TIRR," Nature Communications, Nature, vol. 9(1), pages 1-12, December.
    4. Amélie Fradet-Turcotte & Marella D. Canny & Cristina Escribano-Díaz & Alexandre Orthwein & Charles C. Y. Leung & Hao Huang & Marie-Claude Landry & Julianne Kitevski-LeBlanc & Sylvie M. Noordermeer & F, 2013. "53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark," Nature, Nature, vol. 499(7456), pages 50-54, July.
    5. Qi Hu & Maria Victoria Botuyan & Debiao Zhao & Gaofeng Cui & Elie Mer & Georges Mer, 2021. "Mechanisms of BRCA1–BARD1 nucleosome recognition and ubiquitylation," Nature, Nature, vol. 596(7872), pages 438-443, August.
    6. Jiaxu Wang & Zenglin Yuan & Yaqi Cui & Rong Xie & Guang Yang & Muzaffer A. Kassab & Mengxi Wang & Yinliang Ma & Chen Wu & Xiaochun Yu & Xiuhua Liu, 2018. "Molecular basis for the inhibition of the methyl-lysine binding function of 53BP1 by TIRR," Nature Communications, Nature, vol. 9(1), pages 1-9, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jian Ma & Yingke Zhou & Penglin Pan & Haixin Yu & Zixi Wang & Lei Lily Li & Bing Wang & Yuqian Yan & Yunqian Pan & Qi Ye & Tianjie Liu & Xiaoyu Feng & Shan Xu & Ke Wang & Xinyang Wang & Yanlin Jian & , 2023. "TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    2. Nikolaos Parisis & Pablo D. Dans & Muhammad Jbara & Balveer Singh & Diane Schausi-Tiffoche & Diego Molina-Serrano & Isabelle Brun-Heath & Denisa Hendrychová & Suman Kumar Maity & Diana Buitrago & Rafa, 2023. "Histone H3 serine-57 is a CHK1 substrate whose phosphorylation affects DNA repair," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    3. George E. Ronson & Katarzyna Starowicz & Elizabeth J. Anthony & Ann Liza Piberger & Lucy C. Clarke & Alexander J. Garvin & Andrew D. Beggs & Celina M. Whalley & Matthew J. Edmonds & James F. J. Beesle, 2023. "Mechanisms of synthetic lethality between BRCA1/2 and 53BP1 deficiencies and DNA polymerase theta targeting," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    4. Michael Kosicki & Felicity Allen & Frances Steward & Kärt Tomberg & Yangyang Pan & Allan Bradley, 2022. "Cas9-induced large deletions and small indels are controlled in a convergent fashion," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    5. John J. Krais & David J. Glass & Ilse Chudoba & Yifan Wang & Wanjuan Feng & Dennis Simpson & Pooja Patel & Zemin Liu & Ryan Neumann-Domer & Robert G. Betsch & Andrea J. Bernhardy & Alice M. Bradbury &, 2023. "Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilities," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    6. Ron Baik & M. Kyle Cromer & Steve E. Glenn & Christopher A. Vakulskas & Kay O. Chmielewski & Amanda M. Dudek & William N. Feist & Julia Klermund & Suzette Shipp & Toni Cathomen & Daniel P. Dever & Mat, 2024. "Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cells," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    7. Chao Yang & Zhenzhen Ma & Keshan Wang & Xingxiao Dong & Meiyu Huang & Yaqiu Li & Xiagu Zhu & Ju Li & Zhihui Cheng & Changhao Bi & Xueli Zhang, 2023. "HMGN1 enhances CRISPR-directed dual-function A-to-G and C-to-G base editing," Nature Communications, Nature, vol. 14(1), pages 1-12, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41821-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.